Stockhub

NanoenTek,Inc.

Page Discussion
Revision as of 15:03, 22 September 2022 by Nick (talk | contribs) (Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device fo...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Summary[1]Edit

NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device for counting the residual white blood cells; ADAMII, a fluorescence stem cell counter; EVE, a benchtop counter to measure cell count and viability; Arthur/fluorescence cell counters; automated somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 2000 and is headquartered in Seoul, South Korea.

References and notesEdit

  1. ↑ Source: Yahoo Finance.
Retrieved from ‘https://stockhub.co/index.php?title=NanoenTek,Inc.&oldid=61954’